International, randomized, open label study to compare the safety and efficacy of lixisenatide vs sulfonylurea on top of basal insulin treatment in Type 2 Diabetes Mellitus subjects who elect to fast during Ramadan

drug protocol number
LPS14410
drug sponsor
Sanofi
drug study
Lixisenatide
drug trial site
King Khalid University Hospital (Riyadh)
drug status
Terminated
drug phase